Page last updated: 2024-10-30

lansoprazole and Galactorrhea

lansoprazole has been researched along with Galactorrhea in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Galactorrhea: Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duwicquet, F1
Gras-Champel, V1
Masmoudi, K1
Izquierdo Prieto, OM1
Moreno Alía, E1
Rosillo González, A1

Other Studies

2 other studies available for lansoprazole and Galactorrhea

ArticleYear
[Hyperprolactinemia with galactorrhea induced by lansoprazole: A case report].
    Therapie, 2017, Volume: 72, Issue:6

    Topics: Adolescent; Female; Galactorrhea; Humans; Hyperprolactinemia; Lansoprazole; Proton Pump Inhibitors

2017
[Galactorrhea induced by lansoprazole].
    Atencion primaria, 2004, Oct-15, Volume: 34, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Galactorrhea; Humans; Lansoprazole; Male; Omeprazole

2004